138135-48-5

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 4-(3-Aminophenyl)-5-(Methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and functional groups make it a valuable component in the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Industry:
In the agrochemical sector, Ethyl 4-(3-Aminophenyl)-5-(Methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate is utilized as a precursor in the production of agrochemicals. Its properties may contribute to the creation of effective pesticides, herbicides, or other agricultural chemicals that can enhance crop protection and yield.
Used in Drug Development Research:
Ethyl 4-(3-AMinophenyl)-5-(Methoxycarbonyl)-2,6-diMethyl-1,4-dihydropyridine-3-carboxylate is also used as a research target in drug development. Its complex structure and potential biological activity make it a promising candidate for the discovery of new therapeutic agents, particularly in the areas of cardiovascular, neurological, or other medical fields where dihydropyridine-based drugs have shown efficacy.
Used in Chemical Synthesis:
Ethyl 4-(3-Aminophenyl)-5-(Methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate serves as a versatile building block in chemical synthesis. Its functional groups can be modified or used as starting points for the creation of a wide range of chemical products, including specialty chemicals, materials, or other complex organic compounds.

Upstream product

• 39562-70-4 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester 

Relevant academic research and scientific papers

Dihydropyridine neuropeptide Y Y1 receptor antagonists

Dihydropyridine 5a was found to be an inhibitor of neuropeptide Y1 binding in a high throughput 125I-PYY screening assay. Structure-activity studies around certain portions of the dihydropyridine chemotype identified BMS-193885 (6e)

DIHYDROPYRIDINE NPY ANTAGONISTS: PIPERAZINE DERIVATIVES

A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of piperazine and homopiperazine derivatives of 4-phenyl-1,4-dihydropyridines of Formula (I). STR1 As antagonists of NPY-induced feeding behavior, these compounds are e

DIHYDROPYRIDINE NPY ANTAGONISTS: NITROGEN HETEROCYCLIC DERIVATIVES

A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of nitrogen heterocyclic derivatives of 4-phenyl-1,4-dihydropyridines of Formula (I). STR1 As antagonists of NPY-induced feeding behavior, these compounds are expected

Process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines

A process for the optical resolution of racemic 1,4-dihydropyridines, containing isothioureido groups. Salification of racemic isothioureas with optically active acids produces diasteroisomeric mixtures of isothiouronium salts, that, using conventional techniques, are separated in the individual components to give optically pure isothioureides of 1,4-dihydropyridines and salts thereof with conventional acids. Said optically pure 1,4-dihydropyridines can then be subjected to desulphuration and to different transformations to give to other enantiomerically pure and therapeutically useful 1,4-dihydropyridines.